{"classes":[{"categories":[{"measurements":[{"comment":"The upper limit is not applicable due an to insufficient number of participants with events.","groupId":"OG000","lowerLimit":"36.1","upperLimit":"NA","value":"77.0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"}],"units":"Participants"}],"description":"The TTNT is measured from the date of initiation of treatment to the start date of the next treatment regimen.","dispersionType":"95% Confidence Interval","groups":[{"description":"All participants who received at least two cycles of CFZ either at 27mg/m\\^2, 36mg/m\\^2, 45 mg/m\\^2, or 56mg/m\\^2.","id":"OG000","title":"CFZ With Bendamustine and Dexamethasone"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"Up to 6.5 years","title":"Time to Next Treatment (TTNT)","type":"SECONDARY","unitOfMeasure":"months"}